769 total citations 18 papers, 580 citations indexed
About
De Vos M is a scholar working on Epidemiology, Rheumatology and Genetics.
According to data from OpenAlex, De Vos M has authored 18 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Rheumatology and 5 papers in Genetics. Recurrent topics in De Vos M's work include Spondyloarthritis Studies and Treatments (9 papers), Inflammatory Bowel Disease (5 papers) and Microscopic Colitis (4 papers). De Vos M is often cited by papers focused on Spondyloarthritis Studies and Treatments (9 papers), Inflammatory Bowel Disease (5 papers) and Microscopic Colitis (4 papers). De Vos M collaborates with scholars based in Belgium. De Vos M's co-authors include Herman Mielants, Veys Em, C Cuvelier, Claude Cuvelier, Stefan Goemaere, L Schatteman, Dirk Elewaut, Lieve Gyselbrecht, Rik Joos and Lucien Noens and has published in prestigious journals such as PubMed.
In The Last Decade
De Vos M
16 papers
receiving
559 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of De Vos M's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Vos M with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Vos M more than expected).
This network shows the impact of papers produced by De Vos M. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Vos M. The network helps show where De Vos M may publish in the future.
Co-authorship network of co-authors of De Vos M
This figure shows the co-authorship network connecting the top 25 collaborators of De Vos M.
A scholar is included among the top collaborators of De Vos M based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with De Vos M. De Vos M is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
18 of 18 papers shown
1.
Delrue, Louke, A Kelles, Frederik Berrevoet, et al.. (2008). Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?. PubMed. 70(4). 331–8.33 indexed citations
2.
M, De Vos. (2003). Standard and innovative therapy of inflammatory bowel diseases.. PubMed. 20(6 Suppl 28). S95–100.
3.
Schoonjans, Renaat, et al.. (2001). Dyspepsia and gastric emptying in chronic renal failure patients.. PubMed. 56(4). 302–7.16 indexed citations
4.
Mielants, Herman, et al.. (2000). Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.. PubMed. 27(12). 2860–5.187 indexed citations
5.
Mielants, Herman, et al.. (1995). Immunopathogenetic mechanisms in spondylarthropathy and gut inflammation.. PubMed. 371B. 1379–80.1 indexed citations
6.
Mielants, Herman, Veys Em, Claude Cuvelier, et al.. (1995). The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.. PubMed. 22(12). 2279–84.150 indexed citations
7.
Cuvelier, Claude, Herman Mielants, De Vos M, J. Quatacker, & Eric Veys. (1995). Idiopathic inflammatory bowel diseases: immunological hypothesis.. PubMed. 57(5-6). 292–9.3 indexed citations
8.
Quatacker, J., et al.. (1993). M cells are damaged and increased in number in inflamed human ileal mucosa.. PubMed. 31(1-2). 87–91.27 indexed citations
9.
Cuvelier, Claude, Herman Mielants, J. Quatacker, et al.. (1992). Spondylarthropathy and gut inflammation: immunopathogenetic mechanisms.. PubMed. 14(4). 203–9.4 indexed citations
10.
Mielants, Herman, Stefan Goemaere, De Vos M, et al.. (1991). Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.. PubMed. 18(3). 389–93.28 indexed citations
11.
Mielants, Herman, Veys Em, Claude Cuvelier, & De Vos M. (1990). Subclinical involvement of the gut in undifferentiated spondylarthropathies.. PubMed. 7(5). 499–504.34 indexed citations
12.
Cuvelier, C, et al.. (1990). Ileal mucosal mononuclear cells in patients with seronegative spondylarthropathy.. PubMed. 8(2). 137–43.2 indexed citations
13.
Mielants, Herman, Veys Em, H Verbraeken, De Vos M, & C Cuvelier. (1990). HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation.. PubMed. 17(6). 841–2.13 indexed citations
14.
Mielants, Herman, Veys Em, Rik Joos, Claude Cuvelier, & De Vos M. (1987). Repeat ileocolonoscopy in reactive arthritis.. PubMed. 14(3). 456–8.36 indexed citations
15.
Mielants, Herman, Veys Em, C Cuvelier, De Vos M, & Rik Joos. (1987). Significance of gut inflammation in the seronegative spondyloarthropathies.. PubMed. 5 Suppl 1. S81–7.6 indexed citations
16.
Mielants, Herman, Veys Em, Rik Joos, et al.. (1987). HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation.. PubMed. 14(3). 466–71.39 indexed citations
17.
M, De Vos & F Barbier. (1985). [Measurement of the transepithelial gastric potential difference induced by buffered acetylsalicylic acid. Effects of paracetamol and sucralfate].. PubMed. 9(12 Pt 2). 116–8.1 indexed citations
18.
M, De Vos, et al.. (1974). [Inflammatory steatonecrosis of the alcoholic liver. Personal experience and review of the literature (author's transl)].. PubMed. 36(4). 239–48.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.